This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Welsh Carson settlement ‘blueprint’ caps Biden FTC's crackdown on roll-ups

By Chris May and Ilana Kowarski ( January 18, 2025, 00:04 GMT | Comment) -- A settlement between private equity firm Welsh Carson and the US Federal Trade Commission over allegedly illegal serial acquisitions in the Texas anesthesiology market offers “a valuable blueprint for future Commission orders involving financially sophisticated actors,” the FTC said today. Incoming FTC Chair Andrew Ferguson and fellow Republican Melissa Holyoak signed on to the deal, but also downplayed its significance and suggested new agency leadership won't pursue the private equity industry with as much vigor as Biden administration enforcers. A settlement between private equity firm Welsh Carson, Anderson and Stowe and the US Federal Trade Commission over allegedly illegal serial acquisitions in the Texas anesthesiology market offers “a valuable blueprint for future Commission orders involving financially sophisticated actors,” the FTC said today....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login